Skip to main contentSkip to navigationSkip to search

Behshad Sheldon

Board Member, President Camurus Inc.

Beshad Sheldon

Behshad Sheldon (born 1963) is Board Member since 2018. She is also Member of the Remuneration Committee. Also, she is since 1 April, 2024, President of Camurus Inc. 

Her work experience includes the position as President & CEO of Braeburn Pharmaceuticals until 2017. She has also extensive global and US experience from various senior positions in international pharmaceutical companies, including Smithkline Beecham, Bristol-Myers Squibb, Otsuka Pharmaceuticals and as EVP & Managing Director, Biotech Value Advisors.

Beshad holds a B.Sc. in Neuroscience from University of Rochester.

Other current appointments: Chairman of the Board of FORCE (Female Opioid Research and Clinical Experts) in Princeton, New Jersey, Board member of Maxona Pharmaceuticals, Philadelphia, Pennsylvania and of Egetis Therapeutics, Stockholm, Sweden.

Holdings: 1,000 shares

Independent in relation to the company’s major shareholders, but not the company and its management.

Board of Directors